<!DOCTYPE html>
<html lang="es">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>An√°lisis de Inversi√≥n: Enovis Corp. (ENOV)</title>
    <link href="https://fonts.googleapis.com/css2?family=Playfair+Display:wght@400;700&family=Inter:wght@300;400;500;600;700&family=JetBrains+Mono:wght@400;500&display=swap" rel="stylesheet">
    <style>
        :root {
            --primary: #1a1a2e;
            --secondary: #16213e;
            --accent: #e94560;
            --gold: #f4a940;
            --success: #00d26a;
            --warning: #ffc107;
            --danger: #dc3545;
            --medtech: #3b82f6;
            --text: #333;
            --text-light: #6c757d;
            --bg-light: #f8f9fa;
            --border: #dee2e6;
        }
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: 'Inter', sans-serif; color: var(--text); line-height: 1.6; }
        .container { max-width: 1200px; margin: 0 auto; padding: 0 2rem; }

        .cover {
            min-height: 100vh;
            background: linear-gradient(135deg, #1e3a8a 0%, #1d4ed8 50%, #2563eb 100%);
            color: white; display: flex; flex-direction: column; justify-content: center;
            align-items: center; text-align: center; padding: 2rem;
        }
        .cover-content { position: relative; z-index: 1; }
        .company-logo {
            width: 120px; height: 120px;
            background: linear-gradient(135deg, var(--medtech), #60a5fa);
            border-radius: 20px; display: flex; align-items: center; justify-content: center;
            margin: 0 auto 2rem; font-size: 3rem;
            box-shadow: 0 20px 60px rgba(59,130,246,0.4);
        }
        .cover h1 { font-family: 'Playfair Display', serif; font-size: 4rem; margin-bottom: 0.5rem; }
        .cover .ticker { font-family: 'JetBrains Mono', monospace; font-size: 1.5rem; opacity: 0.8; margin-bottom: 2rem; }
        .cover .tagline { font-size: 1.25rem; opacity: 0.9; max-width: 600px; margin-bottom: 3rem; }

        .verdict-badge {
            display: inline-block; padding: 1rem 3rem; border-radius: 50px;
            font-size: 1.5rem; font-weight: 700; text-transform: uppercase;
            letter-spacing: 2px; margin-bottom: 2rem;
        }
        .verdict-aceptable { background: linear-gradient(135deg, var(--warning), #ff9800); color: #000; }

        .score-display { font-family: 'Playfair Display', serif; font-size: 6rem; font-weight: 700; }
        .score-label { font-size: 1rem; text-transform: uppercase; letter-spacing: 3px; opacity: 0.8; }
        .cover-meta { position: absolute; bottom: 2rem; font-size: 0.875rem; opacity: 0.6; }

        .section { padding: 4rem 0; border-bottom: 1px solid var(--border); }
        .section-dark { background: var(--bg-light); }
        .section-title { font-family: 'Playfair Display', serif; font-size: 2.5rem; color: var(--primary); margin-bottom: 0.5rem; }
        .section-subtitle { color: var(--text-light); font-size: 1.1rem; margin-bottom: 2rem; }
        .section-number { font-family: 'JetBrains Mono', monospace; font-size: 0.875rem; color: var(--accent); text-transform: uppercase; letter-spacing: 2px; margin-bottom: 0.5rem; }

        .simple-box {
            background: linear-gradient(135deg, var(--medtech) 0%, #2563eb 100%);
            color: white; padding: 3rem; border-radius: 20px; margin-bottom: 2rem;
        }
        .simple-box h3 { font-family: 'Playfair Display', serif; font-size: 1.75rem; margin-bottom: 1.5rem; }
        .simple-box p { font-size: 1.2rem; line-height: 1.8; }

        .analogy-box { background: white; padding: 2rem; border-radius: 15px; border-left: 4px solid var(--gold); margin-top: 2rem; }
        .analogy-box h4 { color: var(--primary); margin-bottom: 0.5rem; }
        .analogy-box p { color: var(--text); }

        .dashboard { display: grid; grid-template-columns: repeat(5, 1fr); gap: 1.5rem; margin-bottom: 2rem; }
        .score-card { background: white; border-radius: 15px; padding: 1.5rem; text-align: center; box-shadow: 0 4px 20px rgba(0,0,0,0.08); }
        .score-card .icon { width: 50px; height: 50px; border-radius: 12px; display: flex; align-items: center; justify-content: center; margin: 0 auto 1rem; font-size: 1.5rem; }
        .score-card .value { font-family: 'JetBrains Mono', monospace; font-size: 2rem; font-weight: 700; color: var(--primary); }
        .score-card .label { font-size: 0.875rem; color: var(--text-light); margin-top: 0.5rem; }
        .score-card .max { font-size: 0.75rem; color: var(--text-light); opacity: 0.6; }
        .pillar-1 .icon { background: #e3f2fd; color: #1976d2; }
        .pillar-2 .icon { background: #e8f5e9; color: #388e3c; }
        .pillar-3 .icon { background: #fff3e0; color: #f57c00; }
        .pillar-4 .icon { background: #f3e5f5; color: #7b1fa2; }
        .pillar-5 .icon { background: #fce4ec; color: #c2185b; }

        .total-score {
            background: linear-gradient(135deg, var(--medtech) 0%, #2563eb 100%);
            color: white; padding: 2rem; border-radius: 15px; text-align: center;
        }
        .total-score .value { font-family: 'Playfair Display', serif; font-size: 4rem; font-weight: 700; }
        .total-score .label { font-size: 1rem; opacity: 0.8; text-transform: uppercase; letter-spacing: 2px; }

        .data-grid { display: grid; grid-template-columns: repeat(3, 1fr); gap: 1.5rem; }
        .data-card { background: white; border-radius: 15px; padding: 1.5rem; box-shadow: 0 4px 20px rgba(0,0,0,0.08); }
        .data-card h4 { font-size: 0.875rem; color: var(--text-light); text-transform: uppercase; margin-bottom: 0.5rem; }
        .data-card .value { font-family: 'JetBrains Mono', monospace; font-size: 1.75rem; font-weight: 600; color: var(--primary); }
        .data-card .change { font-size: 0.875rem; margin-top: 0.25rem; }
        .change.positive { color: var(--success); }
        .change.negative { color: var(--danger); }
        .change.neutral { color: var(--text-light); }

        .styled-table { width: 100%; border-collapse: collapse; background: white; border-radius: 15px; overflow: hidden; box-shadow: 0 4px 20px rgba(0,0,0,0.08); }
        .styled-table th { background: var(--primary); color: white; padding: 1rem; text-align: left; font-weight: 600; }
        .styled-table td { padding: 1rem; border-bottom: 1px solid var(--border); }
        .styled-table tr:last-child td { border-bottom: none; }

        .flag-grid { display: grid; grid-template-columns: repeat(2, 1fr); gap: 1rem; }
        .flag-item { display: flex; align-items: flex-start; gap: 1rem; padding: 1rem; background: white; border-radius: 10px; border-left: 4px solid var(--danger); }
        .flag-item.warning { border-left-color: var(--warning); }
        .flag-item.ok { border-left-color: var(--success); }
        .flag-icon { font-size: 1.5rem; }
        .flag-content h4 { font-size: 0.95rem; color: var(--primary); margin-bottom: 0.25rem; }
        .flag-content p { font-size: 0.85rem; color: var(--text-light); }

        .scenario-cards { display: grid; grid-template-columns: repeat(3, 1fr); gap: 1.5rem; }
        .scenario-card { background: white; border-radius: 15px; padding: 2rem; text-align: center; box-shadow: 0 4px 20px rgba(0,0,0,0.08); }
        .scenario-card.bull { border-top: 4px solid var(--success); }
        .scenario-card.base { border-top: 4px solid var(--warning); }
        .scenario-card.bear { border-top: 4px solid var(--danger); }
        .scenario-card h4 { font-size: 1rem; color: var(--text-light); text-transform: uppercase; margin-bottom: 1rem; }
        .scenario-card .price { font-family: 'Playfair Display', serif; font-size: 2.5rem; font-weight: 700; color: var(--primary); }
        .scenario-card .return { font-size: 1.25rem; font-weight: 600; }
        .scenario-card .return.positive { color: var(--success); }
        .scenario-card .return.negative { color: var(--danger); }
        .scenario-card .probability { font-size: 0.875rem; color: var(--text-light); margin-top: 1rem; }

        .conclusion-box {
            background: linear-gradient(135deg, var(--medtech) 0%, #2563eb 100%);
            color: white; padding: 3rem; border-radius: 20px; text-align: center;
        }
        .conclusion-box h3 { font-family: 'Playfair Display', serif; font-size: 2rem; margin-bottom: 1.5rem; }
        .conclusion-box p { font-size: 1.1rem; opacity: 0.9; max-width: 800px; margin: 0 auto 2rem; line-height: 1.8; }
        .action-buttons { display: flex; gap: 1rem; justify-content: center; flex-wrap: wrap; }
        .action-btn { padding: 1rem 2rem; border-radius: 50px; font-weight: 600; text-transform: uppercase; letter-spacing: 1px; font-size: 0.875rem; }
        .action-btn.primary { background: var(--gold); color: var(--primary); }
        .action-btn.secondary { background: rgba(255,255,255,0.1); color: white; border: 1px solid rgba(255,255,255,0.3); }

        @media (max-width: 968px) { .dashboard, .data-grid { grid-template-columns: repeat(2, 1fr); } .scenario-cards, .flag-grid { grid-template-columns: 1fr; } }
    </style>
</head>
<body>
    <div class="cover">
        <div class="cover-content">
            <div class="company-logo">ü¶¥</div>
            <h1>Enovis Corp.</h1>
            <div class="ticker">NYSE: ENOV</div>
            <p class="tagline">Dispositivos m√©dicos ortop√©dicos - Implantes y rehabilitaci√≥n</p>
            <div class="verdict-badge verdict-aceptable">‚ö†Ô∏è Aceptable - En Transformaci√≥n</div>
            <div class="score-display">55/100</div>
            <div class="score-label">Puntuaci√≥n de Inversi√≥n</div>
        </div>
        <div class="cover-meta">An√°lisis generado el 27 de Enero, 2026 ¬∑ Agente /analista ¬∑ FMA System</div>
    </div>

    <section class="section">
        <div class="container">
            <div class="section-number">Secci√≥n 01</div>
            <h2 class="section-title">Explicaci√≥n Simple</h2>

            <div class="simple-box">
                <h3>¬øQu√© hace Enovis?</h3>
                <p>
                    Enovis fabrica dispositivos m√©dicos para ayudar a la gente a moverse mejor.
                    Desde pr√≥tesis de cadera y rodilla hasta f√©rulas y equipos de rehabilitaci√≥n.
                    Si te rompes un hueso o necesitas un reemplazo de articulaci√≥n, es probable
                    que uses un producto de Enovis o similar.
                </p>
                <div class="analogy-box">
                    <h4>üîß Analog√≠a: El mec√°nico del cuerpo humano</h4>
                    <p>
                        Si tu cuerpo fuera un coche, Enovis ser√≠a el taller que fabrica las piezas
                        de repuesto para cuando algo se rompe o desgasta. Caderas, rodillas, hombros -
                        todos necesitan "repuestos" a medida que envejecemos.
                    </p>
                </div>
            </div>
        </div>
    </section>

    <section class="section section-dark">
        <div class="container">
            <div class="section-number">Secci√≥n 02</div>
            <h2 class="section-title">Dashboard de Puntuaci√≥n</h2>
            <div class="dashboard">
                <div class="score-card pillar-1">
                    <div class="icon">üìä</div>
                    <div class="value">12</div>
                    <div class="max">/20</div>
                    <div class="label">Calidad del Negocio</div>
                </div>
                <div class="score-card pillar-2">
                    <div class="icon">üí∞</div>
                    <div class="value">9</div>
                    <div class="max">/20</div>
                    <div class="label">Fortaleza Financiera</div>
                </div>
                <div class="score-card pillar-3">
                    <div class="icon">üè∞</div>
                    <div class="value">10</div>
                    <div class="max">/20</div>
                    <div class="label">Ventaja Competitiva</div>
                </div>
                <div class="score-card pillar-4">
                    <div class="icon">üëî</div>
                    <div class="value">12</div>
                    <div class="max">/20</div>
                    <div class="label">Gesti√≥n</div>
                </div>
                <div class="score-card pillar-5">
                    <div class="icon">üíµ</div>
                    <div class="value">12</div>
                    <div class="max">/20</div>
                    <div class="label">Valoraci√≥n</div>
                </div>
            </div>
            <div class="total-score">
                <div class="value">55/100</div>
                <div class="label">Puntuaci√≥n Total ¬∑ Aceptable</div>
            </div>
        </div>
    </section>

    <section class="section">
        <div class="container">
            <div class="section-number">Secci√≥n 03</div>
            <h2 class="section-title">An√°lisis del Negocio</h2>
            <div class="data-grid">
                <div class="data-card">
                    <h4>Revenue 2025E</h4>
                    <div class="value">$2.24-2.27B</div>
                    <div class="change positive">~6% organic growth</div>
                </div>
                <div class="data-card">
                    <h4>Precio Acci√≥n</h4>
                    <div class="value">~$31.24</div>
                    <div class="change neutral">Oct 2025</div>
                </div>
                <div class="data-card">
                    <h4>Market Cap</h4>
                    <div class="value">$1.79B</div>
                    <div class="change neutral">Small-cap</div>
                </div>
                <div class="data-card">
                    <h4>Margen Bruto</h4>
                    <div class="value">59.3%</div>
                    <div class="change positive">Mejorando</div>
                </div>
                <div class="data-card">
                    <h4>Leverage</h4>
                    <div class="value">3.2x</div>
                    <div class="change neutral">Target <3x</div>
                </div>
                <div class="data-card">
                    <h4>FCF Conversion 2026E</h4>
                    <div class="value">25%+</div>
                    <div class="change positive">vs -43% en 2024</div>
                </div>
            </div>

            <div style="margin-top: 2rem;">
                <h3 style="color: var(--primary); margin-bottom: 1rem;">Segmentos de Negocio</h3>
                <table class="styled-table">
                    <thead>
                        <tr>
                            <th>Segmento</th>
                            <th>Descripci√≥n</th>
                            <th>% Revenue</th>
                            <th>Crecimiento</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>Reconstructive</strong></td>
                            <td>Implantes quir√∫rgicos (cadera, rodilla, hombro)</td>
                            <td>~50%</td>
                            <td>Alto (post-Lima)</td>
                        </tr>
                        <tr>
                            <td><strong>Prevention & Recovery</strong></td>
                            <td>Bracing, rehabilitaci√≥n, ortopedia</td>
                            <td>~50%</td>
                            <td>Estable</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>
    </section>

    <section class="section section-dark">
        <div class="container">
            <div class="section-number">Secci√≥n 04</div>
            <h2 class="section-title">Transformaci√≥n v√≠a M&A</h2>

            <div style="background: white; border-radius: 15px; padding: 2rem; box-shadow: 0 4px 20px rgba(0,0,0,0.08); border-left: 4px solid var(--medtech);">
                <h4 style="color: var(--primary); margin-bottom: 0.5rem;">Adquisici√≥n de LimaCorporate (Ene 2024)</h4>
                <p style="font-family: 'JetBrains Mono', monospace; font-size: 1.5rem; color: var(--medtech);">‚Ç¨800M (‚Ç¨700M cash + ‚Ç¨100M acciones)</p>
                <p style="color: var(--text-light); margin-top: 1rem;">
                    L√≠der global en implantes ortop√©dicos con sede en Italia. Llev√≥ el segmento Reconstructive
                    a $1B en ingresos. Expandi√≥ presencia internacional significativamente.
                </p>
            </div>

            <div style="margin-top: 2rem; padding: 1.5rem; background: white; border-radius: 10px;">
                <h4 style="color: var(--primary); margin-bottom: 1rem;">Estrategia de Crecimiento</h4>
                <ul style="color: var(--text-light); line-height: 2;">
                    <li><strong>20+ adquisiciones desde 2019</strong> - M&A activo como motor de crecimiento</li>
                    <li><strong>30+ nuevos productos</strong> planeados en pr√≥ximos 3 a√±os</li>
                    <li><strong>Record de 510(k) submissions</strong> a FDA en 2025</li>
                    <li><strong>Nebula hip system</strong> y shoulder portfolio cross-compatible impulsar√°n 2026</li>
                    <li><strong>Internacional: 42%</strong> de ventas (vs 27% en 2019)</li>
                </ul>
            </div>
        </div>
    </section>

    <section class="section">
        <div class="container">
            <div class="section-number">Secci√≥n 05</div>
            <h2 class="section-title">Checklist de Red Flags</h2>
            <div class="flag-grid">
                <div class="flag-item warning">
                    <div class="flag-icon">‚ö†Ô∏è</div>
                    <div class="flag-content">
                        <h4>Leverage elevado (3.2x)</h4>
                        <p>Post-Lima, deuda significativa. Objetivo bajar a <3x antes de m√°s M&A</p>
                    </div>
                </div>
                <div class="flag-item warning">
                    <div class="flag-icon">‚ö†Ô∏è</div>
                    <div class="flag-content">
                        <h4>Integraci√≥n de Lima en curso</h4>
                        <p>Riesgo de ejecuci√≥n en fusiones grandes. FCF negativo en 2024</p>
                    </div>
                </div>
                <div class="flag-item warning">
                    <div class="flag-icon">‚ö†Ô∏è</div>
                    <div class="flag-content">
                        <h4>Small-cap en sector concentrado</h4>
                        <p>Compite contra gigantes como J&J, Stryker, Zimmer Biomet</p>
                    </div>
                </div>
                <div class="flag-item ok">
                    <div class="flag-icon">‚úÖ</div>
                    <div class="flag-content">
                        <h4>Crecimiento org√°nico del 6%</h4>
                        <p>S√≥lido para medtech. Indica demanda real de productos</p>
                    </div>
                </div>
                <div class="flag-item ok">
                    <div class="flag-icon">‚úÖ</div>
                    <div class="flag-content">
                        <h4>FCF mejorando dram√°ticamente</h4>
                        <p>De -43% conversi√≥n en 2024 a 25%+ esperado en 2026</p>
                    </div>
                </div>
                <div class="flag-item ok">
                    <div class="flag-icon">‚úÖ</div>
                    <div class="flag-content">
                        <h4>Pipeline de innovaci√≥n robusto</h4>
                        <p>30+ productos nuevos. Record de submissions FDA</p>
                    </div>
                </div>
                <div class="flag-item ok">
                    <div class="flag-icon">‚úÖ</div>
                    <div class="flag-content">
                        <h4>Insider buying</h4>
                        <p>Ejecutivos comprando acciones (se√±al de confianza)</p>
                    </div>
                </div>
                <div class="flag-item ok">
                    <div class="flag-icon">‚úÖ</div>
                    <div class="flag-content">
                        <h4>Demograf√≠a favorable</h4>
                        <p>Poblaci√≥n envejeciente = m√°s reemplazos de articulaciones</p>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <section class="section section-dark">
        <div class="container">
            <div class="section-number">Secci√≥n 06</div>
            <h2 class="section-title">Valoraci√≥n a 5 A√±os</h2>
            <div class="scenario-cards">
                <div class="scenario-card bull">
                    <h4>üöÄ Integraci√≥n Exitosa</h4>
                    <div class="price">$65+</div>
                    <div class="return positive">+108%</div>
                    <p style="color: var(--text-light); margin-top: 1rem; font-size: 0.9rem;">
                        Lima fully integrated. Revenue $3B+. M√°rgenes expandidos.
                        Multiple re-rating como growth medtech.
                    </p>
                    <div class="probability">Probabilidad: 30%</div>
                </div>
                <div class="scenario-card base">
                    <h4>üìä Crecimiento Moderado</h4>
                    <div class="price">$42</div>
                    <div class="return positive">+34%</div>
                    <p style="color: var(--text-light); margin-top: 1rem; font-size: 0.9rem;">
                        Integraci√≥n OK. Revenue $2.6B. FCF normalizado.
                        Deleverage gradual.
                    </p>
                    <div class="probability">Probabilidad: 45%</div>
                </div>
                <div class="scenario-card bear">
                    <h4>üêª Problemas de Integraci√≥n</h4>
                    <div class="price">$18</div>
                    <div class="return negative">-42%</div>
                    <p style="color: var(--text-light); margin-top: 1rem; font-size: 0.9rem;">
                        Lima decepciona. Competencia presiona m√°rgenes.
                        Deuda pesa. Diluci√≥n forzada.
                    </p>
                    <div class="probability">Probabilidad: 25%</div>
                </div>
            </div>

            <div style="margin-top: 2rem; padding: 2rem; background: white; border-radius: 15px;">
                <h4 style="color: var(--primary); margin-bottom: 1rem;">üìä Valor Esperado: $40.65 (+30%)</h4>
                <p style="color: var(--text-light);">
                    El valor esperado es positivo pero la tesis depende de la ejecuci√≥n de la integraci√≥n
                    de Lima y la mejora del FCF. Para inversores pacientes que crean en el management.
                </p>
            </div>
        </div>
    </section>

    <section class="section">
        <div class="container">
            <div class="section-number">Secci√≥n 07</div>
            <h2 class="section-title">Conclusi√≥n</h2>

            <div class="conclusion-box">
                <h3>‚ö†Ô∏è ACEPTABLE - Oportunidad de Turnaround</h3>
                <p>
                    Enovis est√° en medio de una transformaci√≥n v√≠a la adquisici√≥n de Lima. Si la
                    integraci√≥n es exitosa, el FCF mejora seg√∫n lo planeado, y el pipeline de productos
                    cumple, podr√≠a ser una buena inversi√≥n medtech. Pero el leverage elevado y la
                    ejecuci√≥n en curso a√±aden riesgo. Para inversores que buscan exposici√≥n a ortopedia
                    con upside de turnaround.
                </p>
                <div class="action-buttons">
                    <span class="action-btn primary">Watchlist - Monitorear FCF</span>
                    <span class="action-btn secondary">Posici√≥n M√°x 2-3%</span>
                </div>
            </div>

            <div style="margin-top: 2rem;">
                <h3 style="color: var(--primary); margin-bottom: 1rem;">üìã Alertas</h3>
                <ul style="color: var(--text-light); line-height: 2;">
                    <li><strong>Catalizador:</strong> Q4 2025 y Q1 2026 results (FCF confirmation)</li>
                    <li><strong>Watch:</strong> Leverage ratio <3x (green light para m√°s M&A)</li>
                    <li><strong>Risk:</strong> Si integraci√≥n Lima muestra problemas</li>
                </ul>
            </div>
        </div>
    </section>

    <footer style="background: var(--primary); color: white; padding: 2rem; text-align: center;">
        <p style="opacity: 0.8; font-size: 0.875rem;">An√°lisis generado por Agente /analista ¬∑ FMA System ¬∑ 27 Enero 2026</p>
    </footer>
</body>
</html>